What is prostate acinar carcinoma

Prostate cancer pathology includes acinar adenocarcinoma, ductal adenocarcinoma, urothelial carcinoma, etc., but most of them are prostate acinar carcinoma, so usually prostate cancer acinar refers to prostate cancer, which is an epithelial malignant tumor that occurs in the prostate. It often occurs in the elderly in their seventies and eighties, and the occurrence of prostate cancer is related to genetic factors. In addition, the incidence of prostate cancer is also related to sexual activity and eating habits. People who usually have more sexual activities have a higher risk of prostate cancer.

There are usually no symptoms in the early stages of prostate cancer, but as the disease progresses, the symptoms caused by prostate cancer can be divided into two categories: compression symptoms and metastasis symptoms. The gradual enlargement of the prostate gland will compress the urethra and cause progressive dysuria, manifested as a thin urine stream, short range, incomplete urination, etc., and there will also be frequent urination, urgency, and increased nocturia. Tumor compression of the rectum can cause patients to have difficulty defecating, and can also compress the vas deferens to cause lack of ejaculation. Compression of nerves can cause perineal pain and sciatic pain. Prostate cancer can even invade the bladder, seminal vesicles, blood vessels and other places, causing symptoms such as hematuria and hematospermia. Prostate cancer can also invade the bone marrow and cause anemia or a decrease in the whole blood count, so it should be taken very seriously.

The clinical diagnosis of prostate cancer mainly relies on rectal examination, serum pSA, etc. Because the bone metastasis rate of prostate cancer is high, radionuclide bone scanning is usually performed. Prostate cancer can only be diagnosed through pathological examination of prostate puncture biopsy. For patients with early prostate cancer, treatment methods such as radioactive particle implantation and radical prostatectomy can be used to cure it. For patients with mid-stage prostate cancer, a comprehensive treatment method is usually used, such as surgery-assisted radiotherapy and endocrine therapy-assisted radiotherapy. For patients with hormone-sensitive advanced prostate cancer and hormone-independent prostate cancer, endocrine therapy and second-line endocrine therapy are used respectively. Therefore, once an abnormality in the prostate is found, it must be treated in time, and do not wait until the condition worsens.